BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22911298)

  • 1. A head and neck radiologist's perspective on best practices for the usage of PET/CT scans for the diagnosis and treatment of head and neck cancers.
    Zollinger LV; Wiggins RH
    Arch Otolaryngol Head Neck Surg; 2012 Aug; 138(8):754-8. PubMed ID: 22911298
    [No Abstract]   [Full Text] [Related]  

  • 2. A head and neck surgeon's perspective on best practices for the use of PET/CT scans for the diagnosis and treatment of head and neck cancers.
    Funk GF
    Arch Otolaryngol Head Neck Surg; 2012 Aug; 138(8):748-52. PubMed ID: 22911297
    [No Abstract]   [Full Text] [Related]  

  • 3. Predictive value of positron emission tomography-computed tomography image fusion in the diagnosis of head and neck cancer: does it really improve staging and management?
    de Casso C; Visvanathan V; Soni-Jaiswall A; Kane T; Nigam A
    J Laryngol Otol; 2012 Mar; 126(3):295-301. PubMed ID: 22251666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of 18FFDG PET/CT in the treatment of head and neck cancers: posttherapy evaluation and pitfalls.
    Kapoor V; Fukui MB; McCook BM
    AJR Am J Roentgenol; 2005 Feb; 184(2):589-97. PubMed ID: 15671385
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of positron emission tomography/computed tomography (PET/CT) in head and neck cancer.
    Escott EJ
    Radiol Clin North Am; 2013 Sep; 51(5):881-93. PubMed ID: 24010911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET in face and neck tumours.
    Rankin SC
    Cancer Imaging; 2006 Oct; 6(Spec No A):S89-95. PubMed ID: 17114083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG-PET/CT for detection of the unknown primary head and neck tumor.
    Johansen J; Petersen H; Godballe C; Loft A; Grau C
    Q J Nucl Med Mol Imaging; 2011 Oct; 55(5):500-8. PubMed ID: 22019707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The integrated PET/CT: technological advance in diagnostics of head and neck recurrencies and CUP?].
    Schneider K; Aschoff P; Bihl H; Hagen R
    Laryngorhinootologie; 2006 Mar; 85(3):179-83. PubMed ID: 16547893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The rationale for imaging methods in head and neck oncology].
    Westhofen M
    Laryngorhinootologie; 2006 Oct; 85(10):720-2. PubMed ID: 17031762
    [No Abstract]   [Full Text] [Related]  

  • 10. Investigation of thyroid, head, and neck cancers with PET.
    Zhuang H; Kumar R; Mandel S; Alavi A
    Radiol Clin North Am; 2004 Nov; 42(6):1101-11, viii. PubMed ID: 15488560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of 18FFDG PET/CT in the treatment of head and neck cancers: principles, technique, normal distribution, and initial staging.
    Kapoor V; Fukui MB; McCook BM
    AJR Am J Roentgenol; 2005 Feb; 184(2):579-87. PubMed ID: 15671384
    [No Abstract]   [Full Text] [Related]  

  • 12. FDG-PET staging of head and neck cancer--can improved imaging lead to improved treatment?
    Schwartz DL; Macapinlac HA; Weber RS
    J Natl Cancer Inst; 2008 May; 100(10):688-9. PubMed ID: 18477798
    [No Abstract]   [Full Text] [Related]  

  • 13. The current status of positron-emission tomography scanning in the evaluation and follow-up of patients with head and neck cancer.
    Kutler DI; Wong RJ; Schoder H; Kraus DH
    Curr Opin Otolaryngol Head Neck Surg; 2006 Apr; 14(2):73-81. PubMed ID: 16552262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of PET FDG in the management of head and neck squamous cell cancer.
    Wong WL; Saunders M
    Clin Oncol (R Coll Radiol); 1998; 10(6):361-6. PubMed ID: 9890536
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical impact of positron emission tomography (PET) with (18F)fluorodeoxyglucose (FDG) in head and neck tumours.
    Ekberg T; Sörensen J; Engström M; Blomquist E; Sundin A; Anniko M
    Acta Otolaryngol; 2007 Feb; 127(2):186-93. PubMed ID: 17364351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
    Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of FDG-PET/CT in staging and follow-up of head and neck squamous cell carcinoma.
    Mak D; Corry J; Lau E; Rischin D; Hicks RJ
    Q J Nucl Med Mol Imaging; 2011 Oct; 55(5):487-99. PubMed ID: 22019706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Positron emission tomography in head and neck oncology: five cases].
    Courtois A; Foehrenbach H; Maszelin P; De Dreuille O; Garcia D; Kossowski M; Merlet P; Gaillard JF; Poncet JL
    Ann Otolaryngol Chir Cervicofac; 2001 Sep; 118(4):254-60. PubMed ID: 11679846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography as an effective diagnostic workup in cervical metastasis of carcinoma from an unknown primary tumor.
    Zhao K; Luo XM; Zhou SH; Liu JH; Yan SX; Lu ZJ; Yang SY; Lin LL; Dong MJ
    Cancer Biother Radiopharm; 2012 Dec; 27(10):685-93. PubMed ID: 22834634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness of 18F-FDG PET/CT examination in the diagnosis of head and neck cancer--preliminary results].
    Kuźmińska M; Osuch-Wójcikiewicz E; Fronczewska-Wieniawska K; Królicki L; Niemczyk K
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):17-21. PubMed ID: 22000246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.